# A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults

> **NCT05518500** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **The Jackson Laboratory** · enrollment: 75 (estimated)

## Conditions studied

- Aging
- Influenza Vaccine
- Dendritic Cell
- Vaccine Response

## Interventions

- **BIOLOGICAL:** Flu Vaccine (Year 1)
- **BIOLOGICAL:** Flu Vaccine (Year 2)
- **BIOLOGICAL:** Flu Vaccine (Year 3)
- **BIOLOGICAL:** Flu Vaccine (Year 4)

## Key facts

- **NCT ID:** NCT05518500
- **Lead sponsor:** The Jackson Laboratory
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-31
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05518500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05518500, "A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05518500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*